• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Taiwan·Healthcare·4139.TWO
Share

Ma Kuang Healthcare Holding Limited Stocks

NT$ 37.55Last Updated 30.07.2026

Issuer Rating

3/7
Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

NT$ 55.15M

NT$ 37.55
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Ma Kuang Healthcare Holding Limited, established in 2009 and headquartered in Kaohsiung, Taiwan, functions as an investment holding firm with a broad international and domestic presence in the healthcare sector. The company's core business involves a comprehensive range of medical services, including general community healthcare and specialized traditional Chinese medicine. Beyond direct patient care, Ma Kuang provides Chinese medicinal products, medical management training, and educational support. Its diverse offerings extend to homestay and guardianship services for overseas students, as well as a variety of consulting services encompassing corporate management, computer technology, industry information, and marketing advice. It also offers Chinese medicine beauty services and e-commerce sales. Ma Kuang manages and operates numerous facilities, such as general clinics, community medical clinics, and traditional Chinese medicine clinics, alongside educational institutions. The company further diversifies its activities through the retail sale of dietary supplements, pharmaceuticals, and medical supplies in its stores, involvement in the restaurant industry, and offering leasing and other ancillary services.

Company Valuation

Undervalued
6/7

From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. In particular, the stock is of fair value on EV/EBITDA, undervalued o

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

31.07.2026 01:43

Amazon reported accelerated revenue growth in its cloud business. Its stock jumped 9%.

31.07.2026 01:27

Microsoft Beat Nvidia's Record for Market Capitalization Growth

31.07.2026 01:08

The assets of the "AI-Nostradamus" fund fell to $10 billion following the sale of part of its portfolio

30.07.2026 23:45

OpenAI has lowered the price of GPT-5.6 for budget-conscious customers

30.07.2026 23:38

UEFA has threatened to boycott FIFA tournaments over plans to sell World Cup rights to investors

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026